Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02028455
Title A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

leukemia

non-Hodgkin lymphoma

Therapies

Anti-CD19CAR-CD28-CD3zeta-EGFRt T cells

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.